BARRY J. MULLEN
@Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc
Latest period2024 - Q3ReportedManaged Assets$389.255BTotal holdings2799
Assets growth rate11.68%Assets growth rate (2-Q avg)17.8%Continuous growth in asset value5 quarters
Portfolio positions
This chart displays the top 10 holdings in Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 2799 positions.
Assets under management
The assets under management (AUM) of Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 5 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 389.255B in assets, with a quarterly growth rate of 11.68% and a 2-quarter average growth rate of 17.8%. The portfolio is managed by BARRY J. MULLEN, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
MMCMarsh & Mclennan Cos Inc
| 0.27% | $1.028B 4.609M shares@ $223.09 avg price | Decreased -1.62% |
NKENike Inc
| 0.26% | $987.462M 11.17M shares@ $88.41 avg price | Decreased -15.03% |
NEENextera Energy Inc
| 0.25% | $947.901M 11.214M shares@ $84.54 avg price | Decreased -6.18% |
PANWPalo Alto Networks Inc
| 0.25% | $936.042M 2.739M shares@ $341.81 avg price | Decreased -6.39% |
TAt&t Inc
| 0.23% | $892.127M 40.551M shares@ $22.0 avg price | Decreased -4.18% |
GILDGilead Sciences Inc
| 0.23% | $891.13M 10.629M shares@ $83.85 avg price | Decreased -4.58% |
MELIMercadolibre Inc
| 0.21% | $813.282M 396,344 shares@ $2051.97 avg price | Decreased -18.93% |
REGNRegeneron Pharmaceuticals
| 0.21% | $793.804M 755,112 shares@ $1051.24 avg price | Decreased -10.92% |
SNPSSynopsys Inc
| 0.2% | $777.04M 1.534M shares@ $506.4 avg price | Decreased -4.88% |
BSXBoston Scientific Corp
| 0.2% | $765.086M 9.13M shares@ $83.8 avg price | Decreased -3.86% |